Current status, problems, and perspectives of non-alcoholic fatty liver disease research

por Tanaka, Naoki, Kimura, Takefumi, Fujimori, Naoyuki, Nagaya, Tadanobu, Komatsu, Michiharu, Tanaka, Eiji
Publicado 2019

Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy

por Tanaka, Naoki, Kimura, Takefumi, Fujimori, Naoyuki, Ichise, Yasuyuki, Sano, Kenji, Horiuchi, Akira
Publicado 2020

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study

por Umemura, Takeji, Joshita, Satoru, Shibata, Soichiro, Sugiura, Ayumi, Yamazaki, Tomoo, Fujimori, Naoyuki, Matsumoto, Akihiro, Tanaka, Eiji
Publicado 2019

Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection

por Joshita, Satoru, Sugiura, Ayumi, Umemura, Takeji, Yamazaki, Tomoo, Fujimori, Naoyuki, Matsumoto, Akihiro, Usami, Yoko, Tanaka, Eiji
Publicado 2019

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease

por Shibata, Soichiro, Joshita, Satoru, Umemura, Takeji, Yamazaki, Tomoo, Fujimori, Naoyuki, Ichikawa, Yuki, Komatsu, Michiharu, Matsumoto, Akihiro, Tanaka, Eiji
Publicado 2016

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis

por Kimura, Takefumi, Tanaka, Naoki, Fujimori, Naoyuki, Sugiura, Ayumi, Yamazaki, Tomoo, Joshita, Satoru, Komatsu, Michiharu, Umemura, Takeji, Matsumoto, Akihiro, Tanaka, Eiji
Publicado 2018

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients

por Saito, Hiromi, Umemura, Takeji, Joshita, Satoru, Yamazaki, Tomoo, Fujimori, Naoyuki, Kimura, Takefumi, Komatsu, Michiharu, Matsumoto, Akihiro, Tanaka, Eiji, Ota, Masao
Publicado 2018

Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis

por Sekiguchi, Tomohiro, Umemura, Takeji, Fujimori, Naoyuki, Shibata, Soichiro, Ichikawa, Yuki, Kimura, Takefumi, Joshita, Satoru, Komatsu, Michiharu, Matsumoto, Akihiro, Tanaka, Eiji, Ota, Masao
Publicado 2015

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C

por Yamazaki, Tomoo, Joshita, Satoru, Umemura, Takeji, Usami, Yoko, Sugiura, Ayumi, Fujimori, Naoyuki, Kimura, Takefumi, Matsumoto, Akihiro, Igarashi, Koji, Ota, Masao, Tanaka, Eiji
Publicado 2018

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C

por Yamazaki, Tomoo, Joshita, Satoru, Umemura, Takeji, Usami, Yoko, Sugiura, Ayumi, Fujimori, Naoyuki, Shibata, Soichiro, Ichikawa, Yuki, Komatsu, Michiharu, Matsumoto, Akihiro, Igarashi, Koji, Tanaka, Eiji
Publicado 2017

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease

por Fujimori, Naoyuki, Umemura, Takeji, Kimura, Takefumi, Tanaka, Naoki, Sugiura, Ayumi, Yamazaki, Tomoo, Joshita, Satoru, Komatsu, Michiharu, Usami, Yoko, Sano, Kenji, Igarashi, Koji, Matsumoto, Akihiro, Tanaka, Eiji
Publicado 2018

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy

por Nagaya, Tadanobu, Tanaka, Naoki, Kimura, Takefumi, Kitabatake, Hiroyuki, Fujimori, Naoyuki, Komatsu, Michiharu, Horiuchi, Akira, Yamaura, Takahiro, Umemura, Takeji, Sano, Kenji, Gonzalez, Frank J., Aoyama, Toshifumi, Tanaka, Eiji
Publicado 2015

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study

por Okumura, Taiki, Kimura, Takefumi, Iwadare, Takanobu, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Fujimori, Naoyuki, Kunimoto, Hideo, Komatsu, Michiharu, Fukushima, Hideki, Mori, Hiromitsu, Umemura, Takeji
Publicado 2023

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis

por Joshita, Satoru, Umemura, Takeji, Usami, Yoko, Yamashita, Yuki, Norman, Gary L., Sugiura, Ayumi, Yamazaki, Tomoo, Fujimori, Naoyuki, Kimura, Takefumi, Matsumoto, Akihiro, Igarashi, Koji, Yoshizawa, Kaname, Ota, Masao, Tanaka, Eiji
Publicado 2018

Association between endotoxemia and histological features of nonalcoholic fatty liver disease

por Kitabatake, Hiroyuki, Tanaka, Naoki, Fujimori, Naoyuki, Komatsu, Michiharu, Okubo, Ayaka, Kakegawa, Kyogo, Kimura, Takefumi, Sugiura, Ayumi, Yamazaki, Tomoo, Shibata, Soichiro, Ichikawa, Yuki, Joshita, Satoru, Umemura, Takeji, Matsumoto, Akihiro, Koinuma, Masayoshi, Sano, Kenji, Aoyama, Toshifumi, Tanaka, Eiji
Publicado 2017

Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases

por Sugiura, Ayumi, Joshita, Satoru, Yamashita, Yuki, Yamazaki, Tomoo, Fujimori, Naoyuki, Kimura, Takefumi, Matsumoto, Akihiro, Wada, Shuichi, Mori, Hiromitsu, Shibata, Soichiro, Yoshizawa, Kaname, Morita, Susumu, Furuta, Kiyoshi, Kamijo, Atsushi, Iijima, Akihiro, Kako, Satoko, Maruyama, Atsushi, Kobayashi, Masakazu, Komatsu, Michiharu, Matsumura, Makiko, Miyabayashi, Chiharu, Ichijo, Tetsuya, Takeuchi, Aki, Koike, Yuriko, Gibo, Yukio, Tsukadaira, Toshihisa, Inada, Hiroyuki, Nakano, Yoshiyuki, Usuda, Seiichi, Kiyosawa, Kendo, Tanaka, Eiji, Umemura, Takeji
Publicado 2020